Entero Healthcare Solutions Ltd. Cash Flow Conversion Efficiency
Entero Healthcare Solutions Ltd. cash flow conversion efficiency. Based on the latest financial reports, Entero Healthcare Solutions Ltd. (ENTERO) has a cash flow conversion efficiency ratio of -0.032x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs-572.73 Million ≈ $-6.19 Million USD) by net assets (Rs17.97 Billion ≈ $194.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Entero Healthcare Solutions Ltd. (2019–2025)
Cash flow conversion efficiency of Entero Healthcare Solutions Ltd. from 2019 to 2025. This chart illustrates how Entero Healthcare Solutions Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. View current stock price of Entero Healthcare Solutions Ltd. for real-time trading data and today's change.
Entero Healthcare Solutions Ltd. Cash Flow Conversion Ratio Explained
Entero Healthcare Solutions Ltd. cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Entero Healthcare Solutions Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Entero Healthcare Solutions Ltd. ranked by their cash flow conversion efficiency. Also see market value of Entero Healthcare Solutions Ltd. for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Direcional Engenharia S.A.
SA:DIRR3
|
0.055x |
|
Asiainfo Security Technologies Corp. A
SHG:688225
|
N/A |
|
Hunan Changgao High Voltage Switchgear Group Co Ltd
SHE:002452
|
0.057x |
|
Cikarang Listrindo Tbk PT
JK:POWR
|
0.074x |
|
GrocerIQ, Inc
NYSE:WPFHD
|
N/A |
|
Array Technologies Inc
NASDAQ:ARRY
|
0.068x |
|
Synsam AB
ST:SYNSAM
|
0.144x |
|
Hotel Shilla
KO:008770
|
-0.137x |
Annual Cash Flow Conversion Efficiency for Entero Healthcare Solutions Ltd. (2019–2025)
The table below shows the annual cash flow conversion efficiency of Entero Healthcare Solutions Ltd. from 2019 to 2025. Review Entero Healthcare Solutions Ltd. (ENTERO) free cash flow to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-09-30 | Rs17.53 Billion ≈ $189.53 Million |
Rs693.22 Million ≈ $7.50 Million |
0.040x | +187.18% |
| 2024-09-30 | Rs17.70 Billion ≈ $191.46 Million |
Rs-803.24 Million ≈ $-8.69 Million |
-0.045x | -103.41% |
| 2023-09-30 | Rs16.41 Billion ≈ $177.51 Million |
Rs-366.12 Million ≈ $-3.96 Million |
-0.022x | +69.10% |
| 2022-09-30 | Rs6.28 Billion ≈ $67.89 Million |
Rs-453.15 Million ≈ $-4.90 Million |
-0.072x | -15.29% |
| 2021-09-30 | Rs5.63 Billion ≈ $60.91 Million |
Rs-352.66 Million ≈ $-3.81 Million |
-0.063x | +55.60% |
| 2020-09-30 | Rs4.87 Billion ≈ $52.67 Million |
Rs-686.84 Million ≈ $-7.43 Million |
-0.141x | -63.81% |
| 2019-09-30 | Rs4.24 Billion ≈ $45.88 Million |
Rs-365.19 Million ≈ $-3.95 Million |
-0.086x | -- |
About Entero Healthcare Solutions Ltd.
Entero Healthcare Solutions Limited engages in the distribution and marketing of pharmaceutical, surgical products and other allied services in India. The company involved in the distribution of generic formulations, active pharmaceutical ingredients, surgical consumables, rehabilitation products and devices, over the counter medical products, nutraceuticals, biosimilars, and biologics. It also p… Read more